COVID-19: Your safety is our priority. Amidst the COVID-19 outbreak, we are doing our part to keep our clients and team members safe and healthy. The wheels of justice are still moving, but you can stay home while we fight for you. Learn More about the precautions Whitley Law Firm is taking to minimize the spread of COVID-19 and read more about Frequently Asked Questions regarding how the outbreak could affect your case.

The Link Between BIA-ALCL and Breast Implants

The Link Between BIA-ALCL and Breast Implants

The Food and Drug Administration (FDA) has issued a press release regarding breast plant labeling and telling manufacturers to add a warning about the risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). BIA-ALCL is a type of lymphoma that can develop around breast implants and occurs frequently in patients who have implants with textured surfaces. BIA-ALCL is not breast cancer, but a cancer of the immune system.

The FDA also issued a report that stated the number of BIA-ALCL cases increased by 28% in the last half of 2019, and the cases were specifically linked to breast implants with textured designs. In a study conducted by Columbian researchers, it was discovered that many breast implant brands are associated with BIA-ALCL. Speak with an attorney today to learn more.

Who is to Blame?

The company Allergan has been found by the FDA to have a link between their products and an increased chance of cancer. Most cases of BIA-ALCL were specifically linked to the design of particular Allergan Breast Implants.

The FDA found 733 BIA-ALCL diagnoses globally and out of the known cases, 620 have been linked to breast implants sold by Allergan. In addition, 36 patients died globally after being diagnosed with BIA-ALCL and 15 of those deaths were linked to Allergan. Allergan is currently facing at least 150 product liability lawsuits and class action lawsuits over breast implant cancer problems.

What are the Symptoms of BIA-ALCL?

BIA-ALCL is associated with both silicone and saline implants, as well as in both breast cancer reconstruction and cosmetic patients. Currently there is no way to test who is at risk for BIA-ALCL. There are common symptoms of BIA-ALCL which are: breast enlargement, pain, lump in breast or a large fluid collection, and these symptoms can develop as soon as one year after implantation buton average occur 8 to 10 years after the surgery.

Contact an Attorney Today

If a BIA-ALCL diagnosis is made, contact an experienced attorney to see if you have a case; If you have received an Allergan implant and have contracted a worsened medical condition you might be entitled to compensation. Our skilled and dedicated attorneys could help you determine if you have a case, and if you do help you proceed moving forward.